AdvaMed® CEO Scott Whitaker and Board Chairman Michael R. Minogue to Host Press Conference
AdvaMed® will hold a conference call for news media on the upcoming The MedTech Conference and legislative/policy issues in front of the industry today.
AdvaMed® Files Amicus Brief with California Court Opposing New Liability Theory for Products in California Courts
AdvaMed® urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that…
Congress Passes “Historic” MDUFA V Reauthorization
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, has worked alongside FDA and Congressional leaders to negotiate a final agreement that provides FDA…
AdvaMed® Champions Congressional Reauthorization of Vital Small Business Investment Programs
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed®…
AdvaMed® Announces “Stellar” Lineup of Keynote Speakers for 2022 The MedTech Conference
The Advanced Medical Technology Association® (AdvaMed®), which hosts the annual The MedTech Conference, announced the first selection of headline speakers for the upcoming event in Boston from October 24-26, 2022.
AdvaMed® Statement on President Biden’s Cancer Moonshot Update
WASHINGTON, D.C. – Today, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, released the following statement from President and CEO Scott Whitaker in response…
AdvaMed® on EPA’s Commercial Sterilization Facilities List
Scott Whitaker, President and CEO of AdvaMed®, made a statement on EPA’s naming of 23 commercial sterilization facilities as the subject of community meetings over possible health risks.
Whitaker Statement on the Passing of Rep. Walorski
AdvaMed® released the following statement from President and CEO Scott Whitaker on the tragic passing of U.S. Rep. Jackie Walorski (R-Ind.), along with two staff members:
AdvaMed® Urges CMS to Issue Proposed TCET Rule This Year, Offers Direction on Achieving Success for Medicare Beneficiaries to Receive Latest Medical Technologies
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, urged the U.S. Centers for Medicare & Medicaid Services (CMS) to issue its proposed Transitional…
AdvaMed® Applauds Final Passage of CHIPS Act
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, applauded the United States House of Representatives and Senate for coming together to pass the…